On the heels of agreeing to pay $68.5 million to settle several state suits over an antipsychotic drug, AstraZeneca Pharmaceuticals can claim a victory in a related suit filed by labor unions and decided by the Atlanta-based federal appeals court.
The decision continues a trend. While the federal government and states extracted significant settlements from drug companies over alleged illegal marketing, the companies have had success fighting analogous claims by private actors in court.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
